0
21

In This Issue
  |  
FOCUS
Psychopharmacology
Fall 2006, Vol. 4, No. 4
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

LETTER FROM THE EDITORS
Letter from the Editors
Deborah J. Hales, M.D.; Mark Hyman Rapaport, M.D.
Photograph
Commentary
Teaching and Learning Psychopharmacology: A Strategy for the Practicing Physician
James W. Thompson, M.D., M.P.H.; Ira D. Glick, M.D.
CLINICAL SYNTHESIS
CME   The Neurobiological and Therapeutic Intersection of Pain and Affective Disorders
Michael Moskowitz, M.D., M.P.H.; Scott M. Fishman, M.D.
CME   Sedative Hypnotics
Milton Erman, M.D.
Quick Reference for Psychopharmacology
Ask the Expert Psychopharmacology: Major depressive disorder
Sidney Zisook, M.D.
CME   Optimizing Outcomes in Psychopharmacology Continuing Medical Education (CME): Measuring Learning and Attitudes That May Predict Knowledge Translation into Clinical Practice
Stephen M. Stahl, M.D., Ph.D.; Meghan Grady, B.A.; Gerardeen Santiago, Ph.D.; Richard L. Davis
Patient Management Exercise for Psychopharmacology
B. Harrison Levine, M.D., M.P.H.; Ronald C. Albucher, M.D.
REVIEW
CME   Acamprosate for Alcohol Dependence: An Update for the Clinician
Barbara J. Mason, Ph.D.
INFLUENTIAL PUBLICATIONS
Bibliography Psychopharmacology
Abstracts Psychopharmacology
Keeping Our Eyes on STAR?D
Marcia Valenstein, M.D.
STAR?D: The Results Begin to Roll in
Matthew Menza, M.D.
The Search for New Off-Label Indications for Antidepressant, Antianxiety, Antipsychotic and Anticonvulsant Drugs
Guy Chouinard, M.D.
Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic
T. Scott Stroup, M.D., M.P.H.; Jeffrey A. Lieberman, M.D.; Joseph P. McEvoy, M.D.; Marvin S. Swartz, M.D.; Sonia M. Davis, Dr.P.H.; Robert A. Rosenheck, M.D.; Diana O. Perkins, M.D., M.P.H.; Richard S.E. Keefe, Ph.D.; Clarence E. Davis, Ph.D.; Joanne Severe, M.S.; John K. Hsiao, M.D.
Predictors of Recurrence in Bipolar Disorder: Primary Outcomes From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
Roy H. Perlis, M.D.; Michael J. Ostacher, M.D., M.P.H.; Jayendra K. Patel, M.D.; Lauren B. Marangell, M.D.; Hongwei Zhang, M.D., M.S.; Stephen R. Wisniewski, Ph.D.; Terence A. Ketter, M.D.; David J. Miklowitz, Ph.D.; Michael W. Otto, Ph.D.; Laszlo Gyulai, M.D.; Noreen A. Reilly-Harrington, Ph.D.; Andrew A. Nierenberg, M.D.; Gary S. Sachs, M.D.; Michael E. Thase, M.D.
Beyond Efficacy: The STAR?D Trial
Thomas R. Insel, M.D.
Interpreting the Results of the CATIE Study
Jeffrey A. Lieberman, M.D.; John K. Hsiao, M.D.
Suicidal Ideation and Pharmacotherapy Among STEP-BD Patients
Joseph F. Goldberg, M.D.; Michael H. Allen, M.D.; David A. Miklowitz, Ph.D.; Charles L. Bowden, M.D.; Carrie J. Endick, C.S.W.; Cheryl A. Chessick, M.D.; Stephen R. Wisniewski, Ph.D.; Sachiko Miyahara, M.S.; Kemal Sagduyu, M.D.; Michael E. Thase, M.D.; Joseph R. Calabrese, M.D.; Gary S. Sachs, M.D.
Psychiatry in Chronic Pain: A Review and Update
John Sharp, M.D., F.A.P.A., F.A.P.M.; Brian Keefe, M.D.
Antidepressants and Psychotherapy: A Clinical Research Review
Ellen Frank, Ph.D.; Danielle Novick, B.A.; David J. Kupfer, M.D.
  |  
Copyright ©
American
Psychiatric
Association